OptimizeRx
OPRX
OPRX
128 hedge funds and large institutions have $228M invested in OptimizeRx in 2022 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 34 increasing their positions, 54 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
3.27% more ownership
Funds ownership: 76.5% → 79.77% (+3.3%)
1% more funds holding
Funds holding: 127 → 128 (+1)
37% less repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 54
Holders
128
Holding in Top 10
2
Calls
$16.1M
Puts
$380K
Top Buyers
| 1 | +$5.82M | |
| 2 | +$4.37M | |
| 3 | +$3.11M | |
| 4 |
JP Morgan Chase
New York
|
+$2.24M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$2.03M |
Top Sellers
| 1 | -$4.8M | |
| 2 | -$4.31M | |
| 3 | -$2.21M | |
| 4 |
Two Sigma Advisers
New York
|
-$2.03M |
| 5 |
Two Sigma Investments
New York
|
-$1.76M |